These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35888117)

  • 1. Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review.
    Yang CH; Ou YC; Lin CC; Lin YS; Tung MC; Yu CC; Lin JT; Wen CY
    Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phloretin Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Regulating the Inflammatory Response, Oxidative Stress and Apoptosis.
    Hsu CY; Lin YS; Weng WC; Panny L; Chen HL; Tung MC; Ou YC; Lin CC; Yang CH
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
    Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
    Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phloretin Inhibits the Human Prostate Cancer Cells Through the Generation of Reactive Oxygen Species.
    Kim U; Kim CY; Lee JM; Oh H; Ryu B; Kim J; Park JH
    Pathol Oncol Res; 2020 Apr; 26(2):977-984. PubMed ID: 30937835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer.
    Montie JE; Pienta KJ
    Urology; 1994 Jun; 43(6):892-9. PubMed ID: 7515207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
    El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
    Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and chronic prostatic diseases: evidence for a link?
    Sciarra A; Di Silverio F; Salciccia S; Autran Gomez AM; Gentilucci A; Gentile V
    Eur Urol; 2007 Oct; 52(4):964-72. PubMed ID: 17618043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Saussurea costus on apoptosis imbalance and inflammation in benign prostatic hyperplasia.
    Choi DH; Kim JY; An JH; Sung SH; Kong HS
    J Ethnopharmacol; 2021 Oct; 279():114349. PubMed ID: 34171398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
    Liu Y; Zhao X; Sun X; Li Y; Wang Z; Jiang J; Han H; Shen W; Corrigan CJ; Sun Y
    Prostate; 2015 Dec; 75(16):1844-56. PubMed ID: 26356122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
    Zambra FM; Biolchi V; Brum IS; Chies JA
    Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.
    Prajapati A; Gupta S; Mistry B; Gupta S
    Biomed Res Int; 2013; 2013():107954. PubMed ID: 23936768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress in prostate hyperplasia and carcinogenesis.
    Udensi UK; Tchounwou PB
    J Exp Clin Cancer Res; 2016 Sep; 35(1):139. PubMed ID: 27609145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in benign prostatic hyperplasia: a systematic review.
    Minciullo PL; Inferrera A; Navarra M; Calapai G; Magno C; Gangemi S
    Urol Int; 2015; 94(3):249-54. PubMed ID: 25503259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients.
    Cimino S; Favilla V; Russo GI; Galvano F; Li Volti G; Barbagallo I; Giofrè SV; D'Orazio N; DI Rosa A; Madonia M; Morgia G
    Anticancer Res; 2014 Sep; 34(9):5051-6. PubMed ID: 25202090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotyping of angiotensin-converting enzyme in the prostate in patients with prostate cancer and benign prostatic hyperplasia].
    Mamedov VN; Danilov SM; Samokhodskaya LM; Okhobotov DA; Kamalov DM; Melnikov N; Karpov VK; Kadrev AV; Kamalov AA
    Urologiia; 2020 Nov; (5):20-27. PubMed ID: 33185341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and nuclear shapes in benign prostate hyperplasia and prostate adenocarcinoma: comparison with and relation to Gleason score.
    Choi NG; Sohn JH; Park HW; Jung TY
    Int J Urol; 1999 Jan; 6(1):13-8. PubMed ID: 10221859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.